(Q45255862)

11 December 2017

Antagonism by suramin of the growth-inhibitory effect of hydroxytamoxifen and doxorubicin in human MCF-7 breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1512796

3 October 2022

1 reference

1 reference

Y. Berthois

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1512796

3 October 2022

X. F. Dong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1512796

3 October 2022

P. M. Martin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1512796

3 October 2022

E. Cvitkovic

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1512796

3 October 2022

language of work or name

English

0 references

publication date

1 September 1992

1 reference

11 December 2017

16 September 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1512796

Journal of the National Cancer Institute

3 October 2022

published in

1 reference

11 December 2017

84

1 reference

11 December 2017

18

1 reference

11 December 2017

1438-1439

1 reference

11 December 2017

Identifiers

DOI

10.1093/JNCI/84.18.1438

1 reference

11 December 2017

1 reference